Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
20
BIXT Quote, Financials, Valuation and Earnings
Last price:
$0.1000
Seasonality move
:
70.39%
Day range:
$0.0943 - $0.1020
52-week range:
$0.0615 - $0.2283
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
53.82x
P/B ratio:
--
Volume:
27K
Avg. volume:
95.5K
1-year change:
8.31%
Market cap:
$8.6M
Revenue:
--
EPS (TTM):
-$0.04
Earnings Data
Next earnings date for BIXT
Aug 14
2025
Most recent earnings per share
-$0.02
Missed by $0.02
(May 15/2025)
Consensus Estimate
--
(May 15/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BIXT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/15/2025 | Q1 | -- | -- | -$0.02 | -- | -- |
| 12/31/2024 | Q4 | -- | -- | -$0.01 | -- | -- |
| 10/29/2024 | Q3 | -- | -- | -$0.00 | -- | -- |
| 08/14/2024 | Q2 | -- | -- | -$0.00 | -- | -- |
| 04/22/2024 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -- | -- | -- |
| 11/03/2023 | Q3 | -- | -- | -$0.01 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.01 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.01 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.01 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.00 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.01 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.01 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.01 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.00 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.01 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.02 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.01 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.00 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.01 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.01 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.01 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.01 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.00 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.00 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.00 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.00 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$0.00 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.00 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$0.00 | -- | -- |
| 09/30/2017 | Q3 | -- | $112K | $0.05 | -- | -- |
| 06/30/2017 | Q2 | -- | $39.5K | -$0.30 | -- | -- |
| 03/31/2017 | Q1 | -- | $7.4K | -$0.90 | -- | -- |
| 12/31/2016 | Q4 | -- | $58.2K | -- | -- | -- |
| 09/30/2016 | Q3 | -- | $101.1K | -$0.30 | -- | -- |
| 06/30/2016 | Q2 | -- | $55.6K | -$0.30 | -- | -- |
| 03/31/2016 | Q1 | -- | $31.5K | -$0.60 | -- | -- |
| 12/31/2015 | Q4 | -- | -$2.1M | -- | -- | -- |
| 09/30/2015 | Q3 | -- | $110.8K | -$0.07 | -- | -- |
Bioxytran Earnings Questions
-
How Much did Bioxytran Generate in Revenue Last Quarter?
Bioxytran reported -- worth of top line sales in its most recent quarter.
-
Did Bioxytran Beat Earnings Last Quarter?
Bioxytran announced earnings per share of -$0.02 which represents a miss of analyst forecast a -- per share.
-
Is Bioxytran Profitable?
Bioxytran reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Bioxytran EPS Next Year?
Bioxytran's earnings are forecast to grow from -$0.02 per share to -- per share next year representing an increase of --.
-
When is Bioxytran's Earnings Date?
Bioxytran's next earnings date is August 14, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
